[go: up one dir, main page]

MX2007010141A - Procesos para la preparacion de intermedios de linezolid. - Google Patents

Procesos para la preparacion de intermedios de linezolid.

Info

Publication number
MX2007010141A
MX2007010141A MX2007010141A MX2007010141A MX2007010141A MX 2007010141 A MX2007010141 A MX 2007010141A MX 2007010141 A MX2007010141 A MX 2007010141A MX 2007010141 A MX2007010141 A MX 2007010141A MX 2007010141 A MX2007010141 A MX 2007010141A
Authority
MX
Mexico
Prior art keywords
linezolid
processes
preparation
oxazolidinyl
fluorophenyl
Prior art date
Application number
MX2007010141A
Other languages
English (en)
Inventor
Viviana Braude
Serguei Fine
Tamar Nidam
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of MX2007010141A publication Critical patent/MX2007010141A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invencion proporciona metodos mejorados para convertir R-N-(4-morfolinil-3-fluorofenil)-2-oxo-5-oxazolidinil- metil azida (III) en el intermedio de S-N-(4-morfolinil-3- fluorofenil)-2-oxo-5-oxazolidinil-metil amina (II) que implica la produccion de menos subproductos que los metodos previos. La amina (II) luego se convierte en linezolid (I) de alta pureza quimica con respecto al enantiomero R inactivo y a bis-linezolid (IV) y tiene alto rendimiento, sin necesidad de pasos de purificacion tediosos y complicados, tales como la cromatografia.
MX2007010141A 2005-02-24 2006-02-23 Procesos para la preparacion de intermedios de linezolid. MX2007010141A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US65677805P 2005-02-24 2005-02-24
US65664605P 2005-02-24 2005-02-24
US69082205P 2005-06-14 2005-06-14
PCT/US2006/006414 WO2006091731A2 (en) 2005-02-24 2006-02-23 Processes for the preparation of linezolid intermediate

Publications (1)

Publication Number Publication Date
MX2007010141A true MX2007010141A (es) 2007-09-27

Family

ID=36498839

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2007010141A MX2007010141A (es) 2005-02-24 2006-02-23 Procesos para la preparacion de intermedios de linezolid.
MX2007010136A MX2007010136A (es) 2005-02-24 2006-02-24 Bis-linezolid aislado, preparacion de el, y su uso como estandar de referencia.
MX2007010143A MX2007010143A (es) 2005-02-24 2006-02-24 Formas cristalinas de intermedio de linezolid.

Family Applications After (2)

Application Number Title Priority Date Filing Date
MX2007010136A MX2007010136A (es) 2005-02-24 2006-02-24 Bis-linezolid aislado, preparacion de el, y su uso como estandar de referencia.
MX2007010143A MX2007010143A (es) 2005-02-24 2006-02-24 Formas cristalinas de intermedio de linezolid.

Country Status (8)

Country Link
US (4) US7291614B2 (es)
EP (3) EP1866295A2 (es)
JP (2) JP2008530028A (es)
CA (2) CA2602073A1 (es)
IL (3) IL183380A0 (es)
MX (3) MX2007010141A (es)
TW (1) TW200640886A (es)
WO (3) WO2006091731A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011114210A2 (en) 2010-03-15 2011-09-22 Jubilant Life Sciences Limited Processes for the preparation of linezolid
SG185103A1 (en) 2010-04-30 2012-12-28 Univ Indiana Res & Tech Corp Processes for preparing linezolid
EP2690100A1 (en) 2010-08-11 2014-01-29 Synhton B.V. Process for making linezolid
WO2012019632A1 (en) 2010-08-11 2012-02-16 Synthon B.V. Process for making linezolid
WO2012094622A2 (en) * 2011-01-07 2012-07-12 The Regents Of The University Of California Amination of aryl alcohol derivatives
IN2014DN06213A (es) 2012-01-24 2015-10-23 Jubilant Life Sciences Ltd
ES2603252T3 (es) 2012-11-09 2017-02-24 Synthon Bv Proceso para preparar linezolid
EP2989097A4 (en) 2013-04-25 2017-11-08 Symed Labs Limited Improved processes for the preparation of linezolid using novel intermediates
WO2015073779A1 (en) 2013-11-15 2015-05-21 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
CN109265407B (zh) * 2018-10-23 2020-05-29 扬子江药业集团北京海燕药业有限公司 一种双利奈唑胺的合成方法
CN109444294B (zh) * 2018-12-27 2021-06-22 苏州莱奥生物技术有限公司 一种分离利奈唑胺和其手性异构体的高效液相色谱方法
GB202013383D0 (en) * 2020-08-26 2020-10-07 Givaudan Sa Process

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4705799A (en) * 1983-06-07 1987-11-10 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
US4801600A (en) * 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
AU667198B2 (en) 1991-11-01 1996-03-14 Pharmacia & Upjohn Company Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
MY115155A (en) 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
US5750717A (en) * 1994-03-02 1998-05-12 Daicel Chemical Industries, Ltd. 2-isoxazoline derivative and process for producing the same, and process for producing related derivatives from the same
JP3831954B2 (ja) * 1995-05-19 2006-10-11 ダイソー株式会社 ４−ヒドロキシ−２−ピロリドンの製法
GB9812413D0 (en) 1998-06-10 1998-08-05 Glaxo Group Ltd Compound and its use
DE19827282A1 (de) * 1998-06-19 1999-12-23 Bayer Ag Verfahren zur Herstellung von cycloaliphatischen Aminen
AR027261A1 (es) 2000-02-02 2003-03-19 Upjohn Co Linezolid forma cristalina ii
US6444813B2 (en) * 2000-02-02 2002-09-03 Pharmacia & Upjohn Company Linezolid-crystal form II
US6514529B2 (en) * 2000-03-22 2003-02-04 Pharmacia & Upjohn Company Oxazolidinone tablet formulation
YU52403A (sh) * 2000-12-26 2006-03-03 Dr.Reddy's Research Foundation Heterociklična jedinjenja koja imaju antibakterijsko dejstvo, postupak za njihovo dobijanje i farmaceutske smeše koje ih sadrže
WO2002083648A1 (en) * 2001-04-16 2002-10-24 Eisai Co., Ltd. Novel 1h-indazole compound
AU2001100437A4 (en) 2001-10-03 2001-11-01 Pfizer Limited Reference standards for determining the purity or stability of amlodipine maleate and processes therefor
AU2003224345A1 (en) 2002-04-30 2003-11-17 Orchid Chemicals & Pharmaceuticals Antibacterial agents
WO2004026848A1 (en) 2002-09-20 2004-04-01 Lupin Limited Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents
ES2331001T3 (es) * 2003-10-16 2009-12-18 Symed Labs Limited Forma cristalina de linezolid.
EP1745028A2 (en) * 2004-06-29 2007-01-24 Teva Pharmaceutical Industries Ltd Solid forms of linezolid and processes for preparation thereof

Also Published As

Publication number Publication date
EP1861383A2 (en) 2007-12-05
WO2006091848A3 (en) 2006-12-28
WO2006091731A3 (en) 2006-10-19
IL183379A0 (en) 2007-09-20
US20060258655A1 (en) 2006-11-16
US7291614B2 (en) 2007-11-06
JP2008530144A (ja) 2008-08-07
JP2008530028A (ja) 2008-08-07
US20060252932A1 (en) 2006-11-09
WO2006091848A9 (en) 2006-11-09
TW200640886A (en) 2006-12-01
CA2602073A1 (en) 2006-08-31
MX2007010143A (es) 2007-09-27
MX2007010136A (es) 2007-09-27
CA2588876A1 (en) 2006-08-31
WO2006091848A2 (en) 2006-08-31
WO2006091731A2 (en) 2006-08-31
EP1853571A1 (en) 2007-11-14
IL184038A0 (en) 2007-10-31
US20070021417A1 (en) 2007-01-25
EP1866295A2 (en) 2007-12-19
US20080045707A1 (en) 2008-02-21
IL183380A0 (en) 2007-09-20
WO2006091777A1 (en) 2006-08-31

Similar Documents

Publication Publication Date Title
MX2007010141A (es) Procesos para la preparacion de intermedios de linezolid.
TW200712048A (en) Process for the production of alkyl (meth)acrylates
EA201171461A1 (ru) Получение налмефена гидрохлорида из налтрексона
TW200716557A (en) Methods of synthesizing substituted 3-cyanoquinolines and intermediates thereof
WO2011075534A3 (en) Purification of isoprene from renewable resources
WO2009102155A3 (en) Process for preparation of 2-methyl-2´-phenylpropionic acid derivatives and novel intermediate compounds
EP2602314A4 (en) MUTANT MICROORGANISM WITH HIGH PRODUCTION OF CADAVERIN AND METHOD FOR PRODUCING CADAVERIN THEREWITH
EA201101626A1 (ru) Бактерии с высокоэффективным метаболизмом
MY184725A (en) Process for the purification of biomass hydrolysate
MX2023000059A (es) Metodo de preparacion de compuesto de fenilisoxazolina.
WO2010058427A3 (en) Process for production and purification of polymyxin b sulfate
IL178476A0 (en) A new compound ws27713, a process for the production thereof, and a pharmaceutical composition containing the same
TW200740729A (en) Methods for preparing glutamic acid derivatives
TW200738650A (en) Process for synthesis of aryloxy diaminopyrimidines
IN2014KN02722A (es)
PL2099812T3 (pl) Sposób wytwarzania tagatozy z wykorzystaniem izomeryzacji galaktozy o wysokiej wydajności
DK1761478T3 (da) En isoleret Atomoxetin urenhed, fremgangsmåde til fremstilling af Atomoxetin urenheder og deres anvendelse som referencestandarder
PH12012502275A1 (en) Agomelatine intermediates and preparation method thereof
WO2012115402A3 (en) Crystalline form of docetaxel and process for preparation thereof
MD20160071A2 (ro) Procedeu nou de sinteză a agomelatinei
HU0402466D0 (en) Industrial process for preparing 17-hydroxy-6-betha, 7-betha, 15-betha, 16-betha-bis-methylene-3-oxo-17-alpha-pregn-4-ene-21-carboxylic acid gamma lacton and the main, intermediates of the process
MY147768A (en) Method for producing a purified lipase
SG10201907363YA (en) Methods Of Chemical Synthesis Of Diaminophenothiazinium Compounds Including Methylthioninium Chloride (Mtc)
MX2018010128A (es) Toxina nueva y metodo de preparacion de un intermediario de la misma.
WO2014133291A9 (ko) (2rs)-아미노-(3s)-히드록시-부티르산 또는 이의 유도체의 제조방법

Legal Events

Date Code Title Description
FA Abandonment or withdrawal